Validation of IMPS as a prognostic marker in juvenile pilocytic astrocytoma
Sarah Rush, M.D., University of Denver Two-year funding, 2010-2011 Juvenile pilocytic astrocytomas (JPA) are common tumors of childhood. Despite the high incidence, the biological factors that influence outcomes for these children remain poorly understood. Based on our preliminary data, IMP3 represents a highly specific prognostic marker for JPA allowing for improved prediction of outcome. The aim …